Apex Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	593.96	567.09	532.69	382.05	331.71	555.33
Trading Asset Securities	73.96	77.28	66.1	61.87	65.83	69.72
Cash & Short-Term Investments	667.92	644.37	598.78	443.91	397.53	625.05
Cash Growth	12.30%	7.61%	34.89%	11.67%	-36.40%	-24.05%
Accounts Receivable	498.65	437.8	346.64	288.39	486.77	474.41
Other Receivables	12.79	9.81	8.08	5.72	10.12	13.97
Receivables	511.44	447.61	354.72	294.11	496.89	488.38
Inventory	559.17	561.83	662.49	747.71	739.25	628.59
Prepaid Expenses	-	18.82	24.78	18.51	19	11.06
Other Current Assets	20.78	0.98	2.29	2.4	1.81	6.78
Total Current Assets	1,759	1,674	1,643	1,507	1,654	1,760
Property, Plant & Equipment	641.09	652.64	695.81	720.59	766.08	794.12
Long-Term Investments	6.2	-	-	-	-	-
Other Intangible Assets	34.23	35.71	39.6	44.22	69.14	106.48
Long-Term Deferred Tax Assets	6.16	12.8	9.24	4.24	3.62	0.43
Other Long-Term Assets	42.27	41.06	32.23	21.32	21.38	9.58
Total Assets	2,489	2,416	2,420	2,297	2,515	2,670
Accounts Payable	230.73	231.7	239.03	156.22	289.69	343.89
Accrued Expenses	-	154.93	142.25	133.43	150.55	148.07
Short-Term Debt	-	-	-	30	50	150
Current Portion of Leases	6.58	7.69	9.03	7.2	8.01	6.88
Current Income Taxes Payable	31.79	25.88	24.52	46.24	36.92	40.12
Current Unearned Revenue	9.54	7.23	58.28	6.6	29.04	93.06
Other Current Liabilities	282.26	4.62	4.68	3.67	6.35	3.87
Total Current Liabilities	560.9	432.05	477.78	383.35	570.55	785.89
Long-Term Leases	101.82	101.98	113.93	116.2	122.67	127.66
Long-Term Deferred Tax Liabilities	3.25	10.82	3.54	0.04	3.1	2.88
Other Long-Term Liabilities	0.48	0.47	0.47	0.48	0.49	0.48
Total Liabilities	666.46	545.32	595.7	500.07	696.81	916.91
Common Stock	999.5	999.5	999.5	999.5	999.5	999.5
Additional Paid-In Capital	-	-	-	68.37	68.37	68.37
Retained Earnings	742.57	791.23	744.06	718.87	739.95	682.34
Comprehensive Income & Other	79.84	78.98	80.04	9.69	9.51	2.52
Total Common Equity	1,822	1,870	1,824	1,796	1,817	1,753
Minority Interest	0.89	0.77	0.63	0.5	0.57	0.82
Shareholders' Equity	1,823	1,870	1,824	1,797	1,818	1,754
Total Liabilities & Equity	2,489	2,416	2,420	2,297	2,515	2,670
Total Debt	108.4	109.67	122.96	153.4	180.68	284.55
Net Cash (Debt)	559.52	534.69	475.83	290.52	216.85	340.5
Net Cash Growth	16.95%	12.37%	63.79%	33.97%	-36.31%	10.11%
Net Cash Per Share	5.56	5.32	4.74	2.90	2.15	3.22
Filing Date Shares Outstanding	100.34	99.95	99.95	99.95	99.95	99.95
Total Common Shares Outstanding	100.34	99.95	99.95	99.95	99.95	99.95
Working Capital	1,198	1,242	1,165	1,123	1,084	973.97
Book Value Per Share	18.16	18.71	18.25	17.97	18.18	17.54
Tangible Book Value	1,788	1,834	1,784	1,752	1,748	1,646
Tangible Book Value Per Share	17.82	18.35	17.85	17.53	17.49	16.47
Land	-	261.68	261.68	261.68	261.68	261.68
Buildings	-	605.02	605.02	604.13	604.13	601.96
Machinery	-	816.08	806.49	789.71	777.35	754.25